Home › NDC Lookup › RxCUI directory › RxCUI 485415

Alprazolam 0.5 MG Disintegrating Oral Tablet — RxCUI 485415

RxNorm drug concept · Semantic clinical drug
RxCUI 485415 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI485415
Official nameAlprazolam 0.5 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)2,602 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alprazolam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Alprazolam is used to treat generalized anxiety disorder (GAD) and panic disorder — including panic disorder that involves a fear of being in public places (agoraphobia). Different...
  • It can, especially when you first start taking it or if your dose changes. Sedation, sleepiness, and memory or concentration issues are among the most commonly reported side effect...
  • Will alprazolam make me feel drowsy or foggy?
  • Please don't stop on your own — this is really important. Your body can become physically dependent on alprazolam even after short-term use, and stopping suddenly can trigger serio...
📖 Read our full Alprazolam guide →

🕸️ Concept Web — How Alprazolam 0.5 MG Disintegrating Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Alprazolam 0.5 MG Disintegrating Oral Tablet RxCUI 485415

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Alprazolam 596
  2. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alprazolam Disintegrating Oral Tablet 485412
    • Alprazolam Disintegrating Oral Product 1295255
    • Alprazolam Oral Product 1155284
    • Alprazolam Pill 1155285
    • Disintegrating Oral Tablet 316942
    • Disintegrating Oral Product 1294713
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Alprazolam 0.5 MG 317289

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Alprazolam 0.5 MG SCDC · 317289
  • Alprazolam Disintegrating Oral Tablet SCDF · 485412
  • Alprazolam Disintegrating Oral Product SCDG · 1295255
  • Alprazolam Oral Product SCDG · 1155284
  • Alprazolam Pill SCDG · 1155285

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 485415 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-4019-11 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4019-11) Alprazolam Actavis Pharma, Inc. 2010-03-17
00228-4022-11 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4022-11) Alprazolam Actavis Pharma, Inc. 2010-03-17
00228-4024-11 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4024-11) Alprazolam Actavis Pharma, Inc. 2010-03-17
00228-4025-11 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0228-4025-11) Alprazolam Actavis Pharma, Inc. 2010-03-17
49884-0110-74 10 BLISTER PACK in 1 CARTON (49884-110-74) / 10 TABLET, ORA... Alprazolam Par Health USA, LLC 2009-01-09
49884-0111-74 10 BLISTER PACK in 1 CARTON (49884-111-74) / 10 TABLET, ORA... Alprazolam Par Health USA, LLC 2009-01-09
49884-0213-74 10 BLISTER PACK in 1 CARTON (49884-213-74) / 10 TABLET, ORA... Alprazolam Par Health USA, LLC 2009-01-09
49884-0214-74 10 BLISTER PACK in 1 CARTON (49884-214-74) / 10 TABLET, ORA... Alprazolam Par Health USA, LLC 2009-01-09
72189-0637-02 2 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72189-637-02) Alprazolam ODT C-IV Direct_Rx 2025-08-22
Observed labelers: Actavis Pharma, Inc. (4) · Par Health USA, LLC (4) · Direct_Rx (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.